VERAQEN BIOSCIENCES · QUALITY, VERIFIED.
VERAQEN FOUNDING CATALOGUE

Product information, built around evidence.

V0.4 introduces Veraqen’s first five product records while keeping promotional and commerce functions gated until product-specific status and documentation are verified.

Architecture status: These are catalogue records, not representations that the products are authorized for sale in Canada or approved for human use.
Prescription drug pathway

Semaglutide

Regulatory hold

Controlled product identity and documentation record. Promotional and commerce functions remain disabled pending product-specific verification.

View product record →
Peptide product record

BPC-157

Regulatory hold

Controlled product identity and documentation record. Promotional and commerce functions remain disabled pending product-specific verification.

View product record →
Combination peptide record

CJC-1295 + Ipamorelin

Regulatory hold

Controlled product identity and documentation record. Promotional and commerce functions remain disabled pending product-specific verification.

View product record →
Peptide product record

GHK-Cu

Regulatory hold

Controlled product identity and documentation record. Promotional and commerce functions remain disabled pending product-specific verification.

View product record →
Peptide product record

TB-500

Regulatory hold

Controlled product identity and documentation record. Promotional and commerce functions remain disabled pending product-specific verification.

View product record →
VERAQEN VERIFIED

One record. One lot. The right documents.

Each product record is designed to connect to specifications, supplier documentation, lot identifiers, analytical records and applicable jurisdiction-specific status.